ArticleFrontiers in public health2025
Exploring the respiratory viral landscape beyond influenza and SARS-CoV-2: a 2020-2023 study in Fujian, China.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Epidemiology and genetic evolution of Anaplasma species in rodents from southeastern China.Scientific reports · 2026Article
- Epidemiological profile of respiratory viruses associated with influenza-like illness and severe acute respiratory infection in Guangzhou, China, 2024-2025.Frontiers in public health · 2026Article
- Pathogen profiles and co-detection characteristics of acute respiratory infections based on active surveillance in a large district of southern China.Frontiers in public health · 2026Article
- Dynamics of respiratory virus transmission in children during and after COVID-19 outbreak control in Baiyin, China.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In this study, we investigated the local epidemiology and pathogen spectrum of acute respiratory infections caused by common respiratory viruses other than influenza virus (IFV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Fujian Province, China, from September 2020 to December 2023. Methods: Samples negative for IFV and SARS-CoV-2 were randomly selected from individuals presenting with influenza-like illness. These samples were tested for seven common respiratory viruses-human respiratory syncytial virus (HRSV), human parainfluenza virus (HPIV), human adenovirus (HAdV), rhinovirus (RV), human metapneumovirus, human coronavirus (HCoV), and human bocavirus. Quantification fluorescence polymerase chain reaction (qPCR) was used for detection. Results: One or more respiratory viruses were identified in 30.2% ( Discussion: These findings collectively underscore the importance of age-specific and seasonally tailored interventions, as well as the need for comprehensive diagnostic tools capable of simultaneously identifying multiple pathogens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.